Stock market week-in-review for 5 large GI companies — July 24-28

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 24 to July 28.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $250.24 on July 24
Peaked: $256.61 on July 26
Closed: $253.07 on July 28
Percent change between July 24 and July 28: 1.13 percent

2. Exact Sciences Corp.

Opened: $38.94 on July 24
Peaked: $41.96 on July 26
Closed: $39.45 on July 28
Percent change between July 24 and July 28: 2.5 percent

3. Johnson & Johnson

Opened: $134.53 on July 24
Peaked at open
Closed: $131.84 on July 24
Percent change between July 24 and July 28: -1.9 percent

4. Synergy Pharmaceuticals

Opened: $4.25 on July 24
Peaked: $4.32 on July 24
Closed: $4.06 on July 28
Percent change between July 24 and July 28: -4.4 percent

5. Valeant Pharmaceuticals

Opened: $17.51 on July 24
Peaked: $18.09 on July 25
Closed: $16.84 on July 28
Percent change between July 24 and July 28: -3.8 percent

More articles on gastroenterology:
GI leader to know: Dr. Jessica Fisher of Asheville Gastroenterology Associates
GI center to know: Asheville Gastroenterology Associates
Boston Scientific Q2 sales hit $2.25B — 4 insights

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.